Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hope

Showing results (331-340 of 365) with videos related to

Pageof 37
Sort By:
Trials|September 7, 2021
The praziquantel in preschoolers (PIP) trial: study protocol for a phase II PK/PD-driven randomised controlled trial of praziquantel in children under 4 years of ageEmily L Webb, Andrew Edielu, Hannah W Wu, et al.
The Journal of Antimicrobial Chemotherapy|December 7, 2017
Delivering precision antimicrobial therapy through closed-loop control systemsT M Rawson, D O'Hare, P Herrero, et al.
Antimicrobial Agents and Chemotherapy|July 1, 2015
Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistanceF Docobo-Pérez, G L Drusano, A Johnson, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2009
Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysisVidmantas Petraitis, Ruta Petraitiene, William W Hope, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery|August 27, 2024
Research prioritization in hernia surgery: a modified Delphi ACHQC and VHOC expert consensusDaphne Remulla, Mazen R Al-Mansour, Christopher Schneider, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2014
Population pharmacokinetics of teicoplanin in childrenV Ramos-Martín, S Paulus, S Siner, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenaseJason D Oliver, Graham E M Sibley, Nicola Beckmann, et al.
The Lancet. Infectious Diseases|April 29, 2014
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutionsJason A Roberts, Mohd H Abdul-Aziz, Jeffrey Lipman, et al.
The Journal of Infectious Diseases|January 4, 2008
The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonatesWilliam W Hope, Diana Mickiene, Vidmantas Petraitis, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 25, 2020
How to design a study to evaluate therapeutic drug monitoring in infectious diseases?A-G Märtson, M G G Sturkenboom, J Stojanova, et al.
Pageof 37

Showing results (331-340 of 365) with videos related to

Sort By:
Pageof 37
Trials|September 7, 2021
The praziquantel in preschoolers (PIP) trial: study protocol for a phase II PK/PD-driven randomised controlled trial of praziquantel in children under 4 years of ageEmily L Webb, Andrew Edielu, Hannah W Wu, et al.
The Journal of Antimicrobial Chemotherapy|December 7, 2017
Delivering precision antimicrobial therapy through closed-loop control systemsT M Rawson, D O'Hare, P Herrero, et al.
Antimicrobial Agents and Chemotherapy|July 1, 2015
Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistanceF Docobo-Pérez, G L Drusano, A Johnson, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2009
Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysisVidmantas Petraitis, Ruta Petraitiene, William W Hope, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery|August 27, 2024
Research prioritization in hernia surgery: a modified Delphi ACHQC and VHOC expert consensusDaphne Remulla, Mazen R Al-Mansour, Christopher Schneider, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2014
Population pharmacokinetics of teicoplanin in childrenV Ramos-Martín, S Paulus, S Siner, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenaseJason D Oliver, Graham E M Sibley, Nicola Beckmann, et al.
The Lancet. Infectious Diseases|April 29, 2014
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutionsJason A Roberts, Mohd H Abdul-Aziz, Jeffrey Lipman, et al.
The Journal of Infectious Diseases|January 4, 2008
The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonatesWilliam W Hope, Diana Mickiene, Vidmantas Petraitis, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 25, 2020
How to design a study to evaluate therapeutic drug monitoring in infectious diseases?A-G Märtson, M G G Sturkenboom, J Stojanova, et al.
Pageof 37